HC Wainwright & Co. Reiterates Buy on Verastem, Maintains $7 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on Verastem (NASDAQ:VSTM) and maintained a price target of $7.
October 18, 2024 | 11:20 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on Verastem and maintained a $7 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $7 price target by HC Wainwright & Co. suggests a positive outlook for Verastem. This can lead to increased investor confidence and potential upward movement in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100